Renaissance Technologies - CLOVER HEALTH INVESTMENTS CO ownership

CLOVER HEALTH INVESTMENTS CO's ticker is CLOV and the CUSIP is 18914F103. A total of 174 filers reported holding CLOVER HEALTH INVESTMENTS CO in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CLOVER HEALTH INVESTMENTS CO
ValueSharesWeighting
Q3 2023$11,240
+41.6%
10,407,300
+17.6%
0.02%
+72.7%
Q2 2023$7,937
+37.1%
8,847,780
+29.2%
0.01%
+37.5%
Q1 2023$5,788
+41.4%
6,848,400
+55.6%
0.01%
+33.3%
Q4 2022$4,092
-99.9%
4,402,400
+10.6%
0.01%
-40.0%
Q3 2022$6,767,000
+94.1%
3,980,700
+144.3%
0.01%
+150.0%
Q2 2022$3,487,000
+2.9%
1,629,540
+70.7%
0.00%0.0%
Q1 2022$3,390,000954,8000.00%
Other shareholders
CLOVER HEALTH INVESTMENTS CO shareholders Q3 2022
NameSharesValueWeighting ↓
GREENOAKS CAPITAL PARTNERS LLC 96,331,338$728,265,0004.92%
Alphabet Inc. 4,113,742$31,100,0001.25%
Senator Investment Group LP 5,000,000$37,800,0000.78%
Bowie Capital Management, LLC 622,202$4,704,0000.64%
LAKEWOOD CAPITAL MANAGEMENT, LP 1,116,500$8,441,0000.36%
Weiss Asset Management LP 1,000,000$7,560,0000.20%
Pearl River Capital, LLC 81,097$613,0000.20%
Graticule Asia Macro Advisors LLC 150,000$1,134,0000.19%
Casdin Capital, LLC 726,511$5,492,0000.16%
Y-Intercept (Hong Kong) Ltd 75,009$539,0000.14%
View complete list of CLOVER HEALTH INVESTMENTS CO shareholders